{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:28:25Z","timestamp":1791462505376,"version":"4.3.4"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.sapharm.2025.02.009","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:35:38Z","timestamp":1740011738000},"page":"463-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Outcomes of pharmacist-led patient education on oral anticoagulant therapy: A scoping review"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3799-4885","authenticated-orcid":false,"given":"Ahmed A.A.","family":"Omer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1248-042X","authenticated-orcid":false,"given":"Ikhwan Yuda","family":"Kusuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4088-3333","authenticated-orcid":false,"given":"Dezs\u0151","family":"Csupor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7784-6010","authenticated-orcid":false,"given":"P\u00e9ter","family":"Dor\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.sapharm.2025.02.009_bib1","first-page":"351","article-title":"Novel antithrombotic strategies for treatment of venous thromboembolism","volume":"135","author":"Weitz","year":"2020","journal-title":"Blood J Am Soc Hematol"},{"issue":"5","key":"10.1016\/j.sapharm.2025.02.009_bib2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1373\/jalm.2017.025734","article-title":"Venous thromboembolism: role of the clinical laboratory in diagnosis and management","volume":"3","author":"Parakh","year":"2019","journal-title":"J Appl Lab Med"},{"issue":"4","key":"10.1016\/j.sapharm.2025.02.009_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"10.1016\/j.sapharm.2025.02.009_bib4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.114.009107","article-title":"30-year mortality after venous thromboembolism: a population-based cohort study","volume":"130","author":"S\u00f8gaard","year":"2014","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.sapharm.2025.02.009_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026723","article-title":"Trends in oral anticoagulant use among 436 864 patients with atrial fibrillation in community practice, 2011 to 2020","volume":"11","author":"Navar","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.sapharm.2025.02.009_bib6","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.amjmed.2011.06.009","article-title":"Anticoagulation-associated adverse drug events","volume":"124","author":"Piazza","year":"2011","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.sapharm.2025.02.009_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023907","article-title":"Global oral anticoagulation use varies by region in patients with recent diagnosis of atrial fibrillation: the GLORIA-AF phase III registry","volume":"11","author":"Bayer","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.sapharm.2025.02.009_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.sapharm.2025.02.009_bib9","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.sapharm.2025.02.009_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.thromres.2017.07.016","article-title":"Outcomes of an online pharmacist-managed anticoagulation clinic for individuals on warfarin therapy living in rural communities","volume":"157","author":"Zhang","year":"2017","journal-title":"Thromb Res"},{"issue":"13","key":"10.1016\/j.sapharm.2025.02.009_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.sapharm.2025.02.009_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11096-020-01043-y","article-title":"The effect of warfarin knowledge on anticoagulation control among patients with heart valve replacement","volume":"42","author":"Cao","year":"2020","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-018-2874-7","article-title":"A multicenter, prospective study evaluating the impact of the clinical pharmacist-physician counselling on warfarin therapy management in Lebanon","volume":"18","author":"Choumane","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"10.1016\/j.sapharm.2025.02.009_bib22","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s11606-008-0708-8","article-title":"Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events","volume":"23","author":"Metlay","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.sapharm.2025.02.009_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-12-17","article-title":"Practice nursed-based, individual and video-assisted patient education in oral anticoagulation-protocol of a cluster-randomized controlled trial","volume":"12","author":"Hua","year":"2011","journal-title":"BMC Fam Pract"},{"issue":"6","key":"10.1016\/j.sapharm.2025.02.009_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jemermed.2017.06.008","article-title":"Impact of discharge anticoagulation education by emergency department pharmacists at a tertiary academic medical center","volume":"53","author":"Zdyb","year":"2017","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib25","volume":"8","author":"Salone","year":"2019","journal-title":"Clin Pharm: Patient care Med Manag"},{"issue":"6","key":"10.1016\/j.sapharm.2025.02.009_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/ehjqcco\/qcae045","article-title":"The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis","volume":"10","author":"Kefale","year":"2024","journal-title":"Eur Heart J-Qual Care Clin Outcomes"},{"key":"10.1016\/j.sapharm.2025.02.009_bib27","first-page":"378","article-title":"Effectiveness of pharmacist-led anticoagulation management on clinical outcomes: a systematic review and meta-analysis","volume":"20","author":"Hou","year":"2017","journal-title":"J Pharm Pharmaceut Sci"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s40545-022-00486-0","article-title":"Pharmacist management of atrial fibrillation in UK primary care: a qualitative study","volume":"15","author":"Al-Arkee","year":"2022","journal-title":"J Pharm POLICY Pract"},{"issue":"3","key":"10.1016\/j.sapharm.2025.02.009_bib29","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.11.007","article-title":"Knowledge regarding oral anticoagulation therapy among patients with stroke and those at high risk of thromboembolic events","volume":"24","author":"Alphonsa","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.sapharm.2025.02.009_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy8020054","article-title":"Patient knowledge about oral anticoagulation therapy assessed during an intermediate medication review in Swiss community pharmacies","volume":"8","author":"Metaxas","year":"2020","journal-title":"Pharmacy"},{"issue":"2","key":"10.1016\/j.sapharm.2025.02.009_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11096-020-00964-y","article-title":"Evaluation of a program of pharmaceutical counseling for French patients on oral anticoagulant therapy","volume":"42","author":"Roseau","year":"2020","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12913-021-06156-2","article-title":"Impact of pharmacist-conducted anticoagulation patient education and telephone follow-up on transitions of care: a randomized controlled trial","volume":"21","author":"Karaoui","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.sapharm.2025.02.009_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.eurger.2015.04.001","article-title":"Evaluation of family caregivers warfarin knowledge in home-care settings","volume":"6","author":"Aypak","year":"2015","journal-title":"Eur Geriatr Med"},{"issue":"11","key":"10.1016\/j.sapharm.2025.02.009_bib34","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/j.1538-7836.2010.04051.x","article-title":"Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis","volume":"8","author":"Saokaew","year":"2010","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.sapharm.2025.02.009_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.sapharm.2025.02.009_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"7","key":"10.1016\/j.sapharm.2025.02.009_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sapharm.2025.02.009_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"10.1016\/j.sapharm.2025.02.009_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/JPBS.JPBS_188_20","article-title":"The impact of a pharmacist-led warfarin educational video in a Saudi setting","volume":"12","author":"Shilbayeh","year":"2020","journal-title":"J Pharm BioAllied Sci"},{"key":"10.1016\/j.sapharm.2025.02.009_bib40","article-title":"Evaluation of remote pharmacist-led outpatient service for geriatric patients on rivaroxaban for nonvalvular atrial fibrillation during the COVID-19 pandemic","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.sapharm.2025.02.009_bib41","article-title":"Evaluation of a pharmacist-led remote warfarin management model using a smartphone application (yixing) in improving patients' knowledge and outcomes of anticoagulation therapy","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.sapharm.2025.02.009_bib42","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.53350\/pjmhs211551289","article-title":"Prescribing pattern and pharmacist intervention in anticoagulation at A tertiary care teaching hospital, coimbatore, India","volume":"15","author":"Kanafileskookalayeh","year":"2021","journal-title":"Pak J Med Health Sci."},{"issue":"8","key":"10.1016\/j.sapharm.2025.02.009_bib43","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/00325481.2021.1949212","article-title":"Effects of a pharmacist-managed anticoagulation outpatient clinic in Taiwan: evaluation of patient knowledge, satisfaction, and clinical outcomes","volume":"133","author":"Lin","year":"2021","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01394-0","article-title":"Pharmacists' interventions improve health-related quality of life of rural older person on warfarin: a randomized controlled trial","volume":"11","author":"Falami\u0107","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/ijpp.12584","article-title":"Impact of a pharmacist-led education and follow-up service on anticoagulation control and safety outcomes at a tertiary hospital in China: a randomised controlled trial","volume":"28","author":"Liang","year":"2020","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-022-01821-9","article-title":"Evaluation of a pharmacist-led intervention to improve medication adherence in patients initiating dabigatran treatment: a comparison with standard pharmacy practice in Poland","volume":"23","author":"Merks","year":"2022","journal-title":"BMC Prim CARE"},{"issue":"11","key":"10.1016\/j.sapharm.2025.02.009_bib47","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.clinthera.2022.09.011","article-title":"Effects of a pharmacist-led educational interventional program on electronic monitoring-assessed adherence to direct oral anticoagulants: a randomized, controlled trial in patients with nonvalvular atrial fibrillation","volume":"44","author":"Shiga","year":"2022","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.sapharm.2025.02.009_bib48","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.japh.2023.02.019","article-title":"Pharmacist-led, checklist intervention did not improve adherence in ambulatory patients starting\/resuming DOACs","volume":"63","author":"Wilson","year":"2023","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00228-022-03418-8","article-title":"Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service\u2014a cross-sectional study of patients in a Canadian Health Region","volume":"79","author":"Bonsu","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11239-021-02630-0","article-title":"Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study","volume":"54","author":"Jiang","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"10.1016\/j.sapharm.2025.02.009_bib51","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/08971900211000704","article-title":"Impact of a pharmacist intervention in the emergency department on the appropriateness of direct oral anticoagulants prescribed in venous thromboembolism patients","volume":"35","author":"Bakey","year":"2022","journal-title":"J Pharm Pract"},{"issue":"9","key":"10.1016\/j.sapharm.2025.02.009_bib52","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/jac5.1469","article-title":"Drive-up INR testing and phone-based consultations service during COVID-19 pandemic in a pharmacist-lead anticoagulation clinic in Qatar: monitoring, clinical, resource utilization, and patient- oriented outcomes","volume":"4","author":"Alhmoud","year":"2021","journal-title":"J Am Coll Clin Pharm"},{"issue":"8","key":"10.1016\/j.sapharm.2025.02.009_bib53","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/jac5.1285","article-title":"Evaluation of the clinical and safety outcomes of face-to-face vs a telephonic model of a pharmacist-led outpatient anticoagulation service","volume":"3","author":"Saw","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2025.02.009_bib54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-019-01959-x","article-title":"Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center","volume":"49","author":"Patel","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.sapharm.2025.02.009_bib55","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.japh.2021.10.009","article-title":"Pharmacist monitoring of direct oral anticoagulants for American Indians and Alaska Natives in the outpatient setting","volume":"62","author":"Navin","year":"2022","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.sapharm.2025.02.009_bib56","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-022-02743-0","article-title":"Impact of a pharmacist intervention on DOAC knowledge and satisfaction in ambulatory patients","author":"Pham","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"10.1016\/j.sapharm.2025.02.009_bib57","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jppr.1645","article-title":"Outpatient management of deep vein thrombosis using direct oral anticoagulants is safe and efficient","volume":"50","author":"Lim","year":"2020","journal-title":"J Pharm Pract Res"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib58","article-title":"Pharmacist-facilitated interactive E-learning for patients newly initiated on warfarin: a randomised controlled study","volume":"10","author":"Young","year":"2021","journal-title":"Pharm Basel Switz"},{"issue":"4","key":"10.1016\/j.sapharm.2025.02.009_bib59","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s11239-020-02280-8","article-title":"Impact of adherence to warfarin therapy during 12 weeks of pharmaceutical care in patients with poor time in the therapeutic range","volume":"51","author":"Marcatto","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"6 June","key":"10.1016\/j.sapharm.2025.02.009_bib60","article-title":"Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization","volume":"15","author":"Dreijer","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.sapharm.2025.02.009_bib61","doi-asserted-by":"crossref","first-page":"949","DOI":"10.5530\/ijper.58.3.104","article-title":"Safe and effective anticoagulation with warfarin within one-year time period-team work of healthcare professionals","volume":"58","author":"Dhande","year":"2024","journal-title":"Indian J Pharm Educ Res"},{"issue":"2","key":"10.1016\/j.sapharm.2025.02.009_bib62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5530\/jyp.2024.16.42","article-title":"Optimizing oral anticoagulation therapy: impact of pharmacists intervention in patient knowledge and international normalized ratio (INR) control","volume":"16","author":"Thomas","year":"2024","journal-title":"J Young Pharm"},{"issue":"7","key":"10.1016\/j.sapharm.2025.02.009_bib63","doi-asserted-by":"crossref","first-page":"444","DOI":"10.33192\/smj.v76i7.268122","article-title":"Effectiveness of smartphone applications vs conventional care in warfarin therapy: a randomized controlled trial on the time in the therapeutic range","volume":"76","author":"Wongkornrat","year":"2024","journal-title":"Siriraj Med J"},{"issue":"8","key":"10.1016\/j.sapharm.2025.02.009_bib64","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/eurjcn\/zvae092","article-title":"Effects of intensive, targeted education by pharmacists on anticoagulant patients with atrial fibrillation: a multicentre randomized controlled trial from China","volume":"23","author":"Xu","year":"2024","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"7-8","key":"10.1016\/j.sapharm.2025.02.009_bib65","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1345\/aph.1P092","article-title":"Assessing anticoagulation knowledge in patients new to warfarin therapy","volume":"44","author":"Winans","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.sapharm.2025.02.009_bib66","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/11588520-000000000-00000","article-title":"Impact of a pharmacotherapeutic programme on control and safety of long-term anticoagulation treatment: a controlled follow-up study in Spain","volume":"34","author":"Duran-Parrondo","year":"2011","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.sapharm.2025.02.009_bib67","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0897190011415684","article-title":"Factors affecting warfarin-related knowledge and INR control of patients attending physician- and pharmacist-managed anticoagulation clinics","volume":"24","author":"Hasan","year":"2011","journal-title":"J Pharm Pract"},{"issue":"3","key":"10.1016\/j.sapharm.2025.02.009_bib68","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11096-018-0631-y","article-title":"Impact of warfarin discharge education program on hospital readmission and treatment costs","volume":"40","author":"Brunetti","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2025.02.009_bib69","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2710.2010.01216.x","article-title":"Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration","volume":"36","author":"Wong","year":"2011","journal-title":"J Clin Pharm Therapeut"},{"issue":"4","key":"10.1016\/j.sapharm.2025.02.009_bib70","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11096-017-0475-x","article-title":"Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan","volume":"39","author":"Ahmed","year":"2017","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-019-7370-4","article-title":"Impact of an electronic medium delivery of warfarin education in a low income, minority outpatient population: a pilot intervention study","volume":"19","author":"Heinrich","year":"2019","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.sapharm.2025.02.009_bib72","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.pec.2018.12.023","article-title":"Implementation of patient education software in an anticoagulation clinic to decrease visit times for new patient appointments","volume":"102","author":"Patino","year":"2019","journal-title":"Patient Educ Counsel"},{"key":"10.1016\/j.sapharm.2025.02.009_bib73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.22159\/ajpcr.2017.v10s2.19492","article-title":"Effects of pharmacist counseling on compliance and international normalized ratio score on outpatients receiving warfarin at dr. Hasan sadikin bandung hospital west java, Indonesia","volume":"10","author":"Putriana","year":"2017","journal-title":"Asian J Pharmaceut Clin Res"},{"issue":"6","key":"10.1016\/j.sapharm.2025.02.009_bib74","first-page":"1157","article-title":"The role of the clinical pharmacist in patient education and monitoring of patients under warfarin treatment","volume":"23","author":"Izzettin","year":"2019","journal-title":"J Res Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2025.02.009_bib75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jppr.1187","article-title":"A study of consumer retention of key information provided by clinical pharmacists during anticoagulant counselling","volume":"46","author":"Masnoon","year":"2016","journal-title":"J Pharm Pract Res"},{"issue":"10","key":"10.1016\/j.sapharm.2025.02.009_bib76","doi-asserted-by":"crossref","first-page":"314","DOI":"10.22159\/ajpcr.2017.v10i10.16459","article-title":"Impact of pharmacist led anticoagulation monitoring and patient education on oral anticoagulation therapy with acenocoumarol","volume":"10","author":"Chedepudi","year":"2017","journal-title":"Asian J Pharmaceut Clin Res"},{"issue":"3","key":"10.1016\/j.sapharm.2025.02.009_bib77","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1345\/aph.1P617","article-title":"Clinical outcomes of a collaborative, home-based postdischarge warfarin management service","volume":"45","author":"Stafford","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.sapharm.2025.02.009_bib78","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.2042-7174.2012.00217.x","article-title":"The benefits of pharmacist-delivered warfarin education in the home","volume":"20","author":"Stafford","year":"2012","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2753.2008.01110.x","article-title":"Managing oral anticoagulation therapy by pharmacists in a specialty heart hospital","volume":"16","author":"Patel-Naik","year":"2010","journal-title":"J Eval Clin Pract"},{"issue":"9","key":"10.1016\/j.sapharm.2025.02.009_bib80","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1248\/yakushi.18-00209","article-title":"A retrospective evaluation of the impact of multi-disciplinary approach for improving the quality of anticoagulation therapy in ambulatory patients with non-valvular atrial fibrillation receiving warfarin","volume":"139","author":"Ohgushi","year":"2019","journal-title":"J Pharm Soc Jpn"},{"issue":"12","key":"10.1016\/j.sapharm.2025.02.009_bib81","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.ajem.2017.08.001","article-title":"Rivaroxaban program for acute venous thromboembolism upon ED discharge, with focus on utility of commercially available dose pack","volume":"35","author":"Chu","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"6","key":"10.1016\/j.sapharm.2025.02.009_bib82","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11096-017-0511-x","article-title":"Assessment of oral anticoagulation control at two pharmacist-managed clinics in Brazil","volume":"39","author":"de Lima Silva","year":"2017","journal-title":"Int J Clin Pharm"},{"issue":"14","key":"10.1016\/j.sapharm.2025.02.009_bib83","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.2015.2761","article-title":"Site-level variation in and practices associated with dabigatran adherence","volume":"313","author":"Shore","year":"2015","journal-title":"JAMA, J Am Med Assoc"},{"issue":"13","key":"10.1016\/j.sapharm.2025.02.009_bib84","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2146\/ajhp120634","article-title":"Adherence and outcomes of patients treated with dabigatran: pharmacist-managed anticoagulation clinic versus usual care","volume":"70","author":"Lee","year":"2013","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.02.009_bib85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0250-474X.113550","article-title":"Study on impact of clinical pharmacist's interventions in the optimal use of oral anticoagulants in stroke patients","volume":"75","author":"R","year":"2013","journal-title":"Indian J Pharmaceut Sci"},{"issue":"5","key":"10.1016\/j.sapharm.2025.02.009_bib86","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s11096-018-0691-z","article-title":"Pharmacist's interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial","volume":"40","author":"Falami\u0107","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2025.02.009_bib87","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s11096-019-00894-4","article-title":"Pharmacists' influence on adverse reactions to warfarin: a randomised controlled trial in elderly rural patients","volume":"41","author":"Falami\u0107","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"10","key":"10.1016\/j.sapharm.2025.02.009_bib88","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/j.1875-9114.2012.01116","article-title":"Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial","volume":"32","author":"Verret","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.sapharm.2025.02.009_bib89","first-page":"102","article-title":"A pharmacist checklist for direct oral anticoagulant management: raising the bar","volume":"151","author":"Leblanc","year":"2018","journal-title":"Can Pharm J Revue Pharm Can"},{"issue":"8","key":"10.1016\/j.sapharm.2025.02.009_bib90","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/00325481.2021.1949212","article-title":"Effects of a pharmacist-managed anticoagulation outpatient clinic in Taiwan: evaluation of patient knowledge, satisfaction, and clinical outcomes","volume":"133","author":"Lin","year":"2021","journal-title":"Postgrad Med J"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:59:44Z","timestamp":1741885184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741125000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1551741125000373"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.02.009","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of pharmacist-led patient education on oral anticoagulant therapy: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}